Bio-Rad Laboratories, Inc.Class A Earnings Dividend

Bio-Rad Laboratories, Inc.Class A’s revenue fell -0.09% since last year same period to $651Mn in the Q2 2026. On a quarterly growth basis, Bio-Rad Laboratories, Inc.Class A has generated 9.95% jump in its revenue since last 3-months.

Bio-Rad Laboratories, Inc.Class A’s net profit jumped 16.87% since last year same period to $371.4Mn in the Q2 2026. On a quarterly growth basis, Bio-Rad Laboratories, Inc.Class A has generated 170.46% jump in its net profits since last 3-months.

Bio-Rad Laboratories, Inc.Class A’s net profit margin jumped 16.97% since last year same period to 57.05% in the Q2 2026. On a quarterly growth basis, Bio-Rad Laboratories, Inc.Class A has generated 164.09% jump in its net profit margins since last 3-months.

Bio-Rad Laboratories, Inc.Class A’s earning per share (EPS) estimates for the current quarter stand at 2.61 - a 11.54% jump from last quarter’s estimates.

Bio-Rad Laboratories, Inc.Class A’s earning per share (EPS) estimates for the current year stand at 2.61.

Bio-Rad Laboratories, Inc.Class A’s earning per share (EPS) jumped 0.38% since last year same period to 2.62 in the Q2 2026. This indicates that the Bio-Rad Laboratories, Inc.Class A has generated 0.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.